Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 18, 2024 (2 years ago)

Sunitinib Malate Capsules

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Label Mix-Up

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 42291-901-28

Affected NDC 42291-0901-28

Compare with the code on your package — it is the most precise check available.

Drug: Sunitinib

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sunitinib Malate
NDC 42291-0901
12.5 mg/1 Capsule
Oral
AvKARE Rx
Recalling firm
AvKARE
NDC code
42291-901-28
Origin
TN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0103-2025 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Sunitinib recalls

See all
Class II · Moderate risk

Sunitinib Malate Capsules

Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Terminated Failed specification Teva Pharmaceuticals USA Inc NDC 0093-8199-28 D-0913-2023

Other recalls by AvKARE

All 2024 recalls
Class II · Moderate risk

Amantadine HCl

Failed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.

Ongoing Dissolution failure AvKARE NDC 50268-069-15 D-0341-2026